Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 209,600 shares, a decrease of 6.5% from the March 31st total of 224,100 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,096.0 days.

Basilea Pharmaceutica Stock Performance

Basilea Pharmaceutica stock opened at $44.45 on Tuesday. The business has a fifty day moving average of $41.71 and a two-hundred day moving average of $41.26. Basilea Pharmaceutica has a twelve month low of $38.60 and a twelve month high of $44.45.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.